4-Chlorobenzo[d]thiazol-2(3H)-one | CAS:39205-62-4

We serve 4-Chlorobenzo[d]thiazol-2(3H)-one CAS:39205-62-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Chlorobenzo[d]thiazol-2(3H)-one

CAS No: 39205-62-4
Product Name: 4-Chlorobenzo[d]thiazol-2(3H)-one
Other Name:
4-Chlorobenzo[d]thiazol-2(3H)-one
2-Hydroxy-4-chloro benzothiozole
4-Choro-2(3H)-benzothiazolone
 
Density: 1.5±0.1 g/cm3
Melting Point: 204-205℃
Molecular Formula: C7H4ClNOS
Molecular Weight: 185.631
Exact Mass: 184.970215
PSA: 61.10000
LogP: 2.27
Index of Refraction: 1.670
 
Specification
Appearance: White acicular solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Benazolin-Ethyl CAS: 25059-80-7.
Be used as pesticide intermediate, mainly used to synthesize herbicide Benazolin-Ethyl.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 4-Chlorobenzo[d]thiazol-2(3H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Choro-2(3H)-benzothiazolone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Choro-2(3H)-benzothiazolone Use and application,4-Chlorobenzo[d]thiazol-2(3H)-one technical grade,usp/ep/jp grade.


Related News: APIs are generally manufactured through a variety of processes that include.2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid manufacturer The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.Poly(methylhydrosiloxane) supplier The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole vendor With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.